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Introduction: Reminiscence therapy (RT) is a popular psychosocial intervention widely used 
in dementia care. It involves discussion of past events and experiences, using tangible 
prompts to evoke memories or stimulate conversation.  
Areas covered: The aim of this review is to evaluate the effectiveness of RT for people with 
dementia. It includes studies from the specialized register of the Cochrane Dementia and 
Cognitive Improvement Group (ALOIS). Searches yielded 185 records of which 22 (n=1972) 
were eligible for inclusion. The meta-analysis comprised of data from 16 studies (n=1,749 
participants). The review included four large multicentre high-quality studies and several 
smaller studies of reasonable quality. Outcomes of interest were quality of life, 
communication, depression, and cognition at post-treatment and later follow-up.  
Expert Commentary: RT has the potential to improve psychosocial outcomes for people 
with dementia. Effects are small and can be inconsistent, varying across intervention 
modality and setting. Individual approaches were associated with improved cognition and 
mood. Group approaches were linked to improved communication. The impact on quality of 
life appeared most promising in care home settings. Diversity in reminiscence approaches 
makes it difficult to compare them, and the field would benefit from the development, 
evaluation, use, and sharing of standardized approaches.  
 
Keywords:  








Reminiscence therapy (RT) is one of the most popular psychosocial interventions for 
people living with dementia. Although there are many conceptualizations of RT, it is typically 
described as the discussion of past activities, events, and experiences, usually with the aid of 
tangible prompts from the past such as photographs, music, or familiar objects [1]. Digital 
RT has also become popular in recent years, taking advantage of multimedia resources, 
archives, and apps [2].   
RT is often traced back to the work of Butler in the 1960s [3], who introduced the 
concept of life review – the reflection on one’s life experiences, and promoting adjustment 
and integrity. The first identified study of RT for people with dementia was almost 40 years 
ago [4]. Soon after, it was introduced into dementia care by Norris [5] and implemented 
widely. RT soon became popular in practice, though research did not progress with the 
same momentum. However, reminiscence has consistently been found to have positive 
effects on older people with depressed mood [6, 7] including those living in long-term care 
environments [8]. Similarly, life review has been found to be helpful in preventing 
depression and improving quality of life in older adults [9, 10].  From a cognitive standpoint, 
reminiscence may be valuable for people with dementia as there is an emphasis on long-
term memories, which people with dementia (like all older adults) recall more often than 
recent memories [11]. Similarly, earlier memories often represent well-rehearsed 
anecdotes, meaning that RT may be a useful tool for communication because the person 
with dementia can speak confidently about these memories. 
Previous reviews of RT for people with dementia have yielded some positive results, 
though the quality of included studies has been an ongoing concern. In the previous 
Cochrane Review of this topic, Woods and colleagues [1] identified a positive effect of RT on 
cognition scores at later follow-up time points, but not post-treatment. Just five studies 
were included, the authors stressed the need for large, high-quality studies, and the use of 
detailed intervention protocols to ensure transparency regarding the nature of RT used. 
Two reviews found that reminiscence benefitted cognitive function and depressed mood, 
though review authors highlighted the poor quality of included studies and absence of 
intervention protocols [12, 13]. Testad and colleagues [13] also found that reminiscence was 
consistently associated with improved mood, but highlighted the variation in intervention 
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length and frequency among the six included studies. In a review of ten studies, Kwon and 
colleagues [15] found that reminiscence was associated with improved cognitive function 
and quality of life, though the included studies were not referenced. A review focusing on 
individual reminiscence found that structured life review resulting in the production of a life 
storybook had positive psychosocial outcomes for people with dementia, while less 
structured simple reminiscence interventions were not as effective [16]. Kim and colleagues 
[17] focused on group RT and identified a significant benefit to communication and 
cognition.   
Both the volume and quality of reminiscence research has advanced significantly in 
recent years, particularly with the recent completion of new large, multicentre randomized 
controlled trials (RCTs; e.g. [18, 19]). Therefore, a new review of RT for dementia is timely 
and needed.  
This review was carried out with the Cochrane Collaboration Cognitive Impairment and 
Dementia Group [20]. The aim was to review the quality and nature of evidence from 
studies of RT for dementia, and evaluate its effectiveness in the domains of quality of life, 




2.1. Search Method 
 
A systematic search for RCTs evaluating the effects of RT for people with dementia was 
carried out. The search term ‘reminiscence’ was used to search the ALOIS database four 
times between October 2015 and April 2017. Studies were identified from the following 
sources: 
1. Major healthcare databases: Medline, Embase, Cinahl, PsycINFO, and Lilacs 
2. Trial registers: ISRCTN; UMIN (Japan's Trial Register); the WHO portal (which covers 
ClinicalTrials.gov; ISRCTN; the Chinese Clinical Trials Register; the German Clinical Trials 
Register; the Iranian Registry of Clinical Trials and the Netherlands National Trials 
Register, plus others) 
3. The Cochrane Library’s Central Register of Controlled Trials (CENTRAL) 
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4. Grey literature sources: ISI Web of Knowledge Conference Proceedings; Index to 
Theses; Australasian Digital Theses 
5. Additional resources: The Alzheimer's Society library, published letters in the BPS 
(British Psychological Society) magazine, personal contact with various specialists in 
the field.  
2.2. Inclusion criteria 
 
2.2.1. Types of studies 
RCTs (including cluster randomized trials and crossover trials) with a ‘treatment as usual’ 
control group that investigated the effects of RT as an intervention for dementia were 
considered for this review. Studies needed to be published in a peer-reviewed journal, and 
be available in English. There were no specific criteria relating to study settings.  
 
2.2.2. Participants 
Participants with a diagnosis of dementia (of any type or severity) were included. Those 
with mild cognitive impairment (MCI) were not included. Family or professional caregivers 
were included where studies recruited dyads.  
 
2.2.3. Interventions 
Interventions needed to meet the definition of RT described in Section 1 [1] and be 
aimed at people with dementia. The minimum intervention duration was four weeks or six 
reminiscence sessions. Studies were included if a comparison was made to ‘no treatment’, 
‘treatment-as-usual' or passive control conditions such as ‘social contact’. Comparisons with 
other types of activities or therapies were not considered for this review as they could have 
a positive or negative impact on the outcome, making the specific effect of RT unclear. 
 
2.2.4. Outcome measures 
Studies that assessed the effects of a RT intervention on people with dementia were 
included, provided that standardized assessments, rating scales, or questionnaires were 
used. Outcomes that were measured at post-treatment (typically immediately after, or 
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within one month of the intervention) and follow-up (typically one month to six months 
post-intervention) were considered. Outcomes of interest were: 
 
• Quality of life  
• Communication and interaction 
• Depressed mood 
• Cognition 
 
Adverse outcomes were also considered. Possible adverse outcomes were identified 
through negative responses in the quality of life or mood of participants.  
 
2.3. Data extraction and management 
 
Two reviewers (removed for blinding) worked independently to extract descriptive study 
characteristics, quality information, and results of the analyses from published reports. 
Where necessary, additional information was requested from study authors. The mean, 
standard deviation, and number of participants for each treatment group at each time point 
were extracted. The required summary statistics from baseline were calculated by hand. A 
zero correlation between baseline and later assessments was assumed. This is a 
conservative method which overestimates the standard deviation of the change from 
baseline but is considered to be preferable in a meta-analysis. Reviewers (removed for 
blinding) compared and reached consensus on the extracted data and calculated summary 
statistics. The information was recorded and entered into Review Manager (RevMan) 5.3 
software.  
The review authors sought to obtain data from intention to treat analyses. Where this 
was not available, they extracted the data reported on those who completed the trials. In 
cross-over trials, only data from the first intervention phase were included. Where studies 
used cluster randomization, this was adjusted for, if the study was of a sufficient size.   
 
Two review authors independently assessed the quality of each study and rated it using the 
methods and guidelines in the Cochrane Handbook of Systematic Reviews of Interventions 
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[21]. Cluster trials were also assessed for additional biases (see section 3.4.6).   
 
2.4. Data analysis 
 
RevMan 5.3 software (2014) was used. The meta-analyses presented overall estimates of 
the treatment difference from a fixed-effects model.  Heterogeneity was assessed using a 
standard Chi-square statistic and an i2 statistic. To interpret heterogeneity, review authors 
followed Cochrane guidance ([21]; i.e. 0% to 40% might not be important; 30% to 60% may 
represent moderate heterogeneity, 50% to 90% may represent substantial heterogeneity; 
and 75% to 100% is considerable heterogeneity). Where there were high levels of 
heterogeneity of the treatment effect between studies, a random-effects model was used. 
This produces wider confidence intervals than a fixed-effects model. Where pooled trials 
used the same measure to assess an outcome, the mean difference (MD) was used. Where 
pooled trials used different measures to assess the same outcome, the standardized mean 
difference (SMD) was used. Where studies used more than one instrument to measure the 







From the initial set of references identified by the updated systematic searches since the 
previous review [1], 185 additional records were identified across four searches. Records 
were independently screened by reviewers who then reached a consensus. The original 
review [1] included five studies. 16 new studies met the review inclusion criteria [18, 19, 22-
36]. One recruited participants with Alzheimer's disease (AD) and Vascular Dementia (VD) 
but analyzed the two participant groups separately with a different control group for each 
disease type [32, 33]. For the purposes of this review, the review authors considered the 
report to be two separate studies: Tadaka & Kanagawa [32] including participants with AD, 
and Tadaka and Kanagawa [33] including participants with VD. Therefore, a total of 22 
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studies were included in the review (Table 1). Six were excluded from the meta-analyses as 
they were rated as having an unclear risk of selection bias for randomisation [22, 24, 26, 36, 
37, 46]. This process of elimination is depicted in Figure 1. The review authors attempted to 
contact the authors of the more recently published excluded studies for clarification on 
randomization methods but did not receive a response.  
 
 
3.2. Participants, settings, dementia type and severity  
 
Data from 1,972 participants (or dyads) are included in this review. The average 
participant was over 75 years old. 14 studies recruited participants from residential/hospital 
care settings, while eight recruited community-dwelling participants (See Table 1). 
Interventions took place in the care homes where participants resided, or community 
locations such as day centres. 
All studies recruited participants with dementia. Although most did not describe a 
specific diagnosis type in recruitment, three specifically recruited people with a diagnosis of 
AD [23, 24, 28] and one specified a diagnosis of VD [27]. Most studies sought to recruit 
participants in the mild to/or moderate stages of dementia, typically using the CDR, GDS, or 
MMSE to screen potential participants. In most cases it was not possible to extract data for 
participants at each individual ‘stage’ for subgroup analysis.   
 
 
3.3. Reminiscence Interventions 
 
Most studies implemented simple reminiscence interventions whereby participants took 
part in discussions about specific themes of the past in small groups [18, 19, 22, 24, 26-33, 
35-37, 38]. In one study, care staff were trained to deliver simple reminiscence in small 
groups following a structured education programme [29]. Five studies implemented the 
more structured approach of life review [23, 25, 31, 39, 41]. One trial [34] used a 
standardized reminiscence intervention based on the SolCos model (a transformational 
reminiscence model [42]), while another implemented a music reminiscence intervention 
[30]. Three studies implemented joint reminiscence interventions, following the 
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Remembering Yesterday Caring Today (RYCT [44]) program which is a large group based 
approach, bringing together people with dementia and family caregivers with a focus on 
active reminiscence [18, 35, 38]. 
The length of the reminiscence interventions ranged from four weeks (the minimum 
number for inclusion in the review) to 24 months. Three studies held monthly or six-weekly 
maintenance sessions after the initial interview [18, 19, 35]. The total median possible 
reminiscence exposure time was 11.5 hours (3-39 hours), while the median individual 
session length was approximately 53 minutes (30 minutes-2 hours). The session lengths of 
two studies were unclear [29, 38].    
 
3.4. Quality of Studies 
 
Studies were rated as having a low risk (+), unclear risk (?), or high risk (-) of bias in each 
quality domain. Ratings are reported in Table 1.  
 
3.4.1. Randomisation (selection bias) 
All studies randomized participants to treatment or control groups. This was a criterion 
for inclusion in the review. Many used computerized randomization, though some used 
more basic methods, such as sealed envelopes. Three studies used cluster randomization 
[24, 28, 29], and three used an accredited trials unit [18, 31, 35]. As mentioned previously 
(section 3.1), six studies did not detail the method of randomization and were excluded 
from the meta-analyses.  
3.4.2. Allocation concealment (selection bias) 
Allocation concealment details were rarely reported in detail, even when further 
information was requested. Replies generally stated that there had been adequate 
allocation concealment, and in these cases, good practice has been assumed. Low-risk 
methods included the use of independent researchers, remote services, and sealed 
envelopes. 
 
3.4.3. Blinding procedure   
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 As with most psychosocial interventions, participants cannot be blinded to the 
experience of taking part in an intervention (or not taking part in the case of control groups) 
making performance bias challenging to evaluate. 
The majority of studies used independent researchers who were blinded to group 
allocation to complete the outcome assessments. Proxy-rated measures were typically 
completed by a person who knew the participant and could reliably comment.  
Contamination was a risk in care-home based studies in which control and intervention 
participants resided and socialized together. Two studies seemed to have at least one 
person who worked in the care home implement the intervention, meaning that themes of 
reminiscence could have possibly been carried over into daily care and contaminate control 




3.4.4. Incomplete outcome data (attrition bias).  
Five small studies reported zero attrition [22, 25, 37, 38, 41]. The highest attrition rate was 
28% (23% from the intervention group and 34% from the control group) which was reported 
by one of the larger community-based studies [35]. Data extracted from several studies 
were from intention to treat analyses [18, 19, 23, 28, 29, 35, 39], while others carried out 
the analyses without data drop outs [26, 30-34, 36]. One study reported results from both a 
per protocol and ITT analysis, but only data from the per-protocol analysis was extractable 
[27]. In an older study, one participant dropped out and the authors randomly excluded one 
participant from each of the two other groups [40]. The most common reported reasons for 
attrition were the health of the person with dementia, death, the health of the caregiver, 
and the person with dementia moving into residential care. One trial did not report attrition 
rates [24].   
 
3.4.5. Selective reporting 
There was no evidence of selective reporting in any of the included studies. Studies that 
had a protocol [18, 29, 34, 35] detailed the same outcome measures in the protocol as the 
published papers, while other studies reported results on all outcome measures detailed in 
the methods section.  
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3.4.6. Other bias 
Cluster trials were also assessed for other biases associated with clustering such as 
recruitment bias, baseline imbalance, loss of clusters, and comparability with individually 
randomized trials. 
 
3.4.7. Facilitator training and supervision 
O’ Shea and colleagues [29] provided the most training to reminiscence facilitators. They ran 
a structured education-based reminiscence program in which care home staff received 
three days of training. This was augmented by telephone support and site visits. Five studies 
did not report details on facilitator training or reminiscence experience [22, 24, 26, 27, 40]. 
Others did not specify the number of training hours but reported that the intervention was 
delivered by appropriate facilitators, such as psychologists or gerontologists [28, 30-33, 41]. 
The remainder provided between 4 hours and one day of training to facilitators.  
3.4.8. Treatment Protocol.  
The use of a protocol or structure in RT interventions is vital to ensure that the 
intervention is delivered as intended, and reflects true RT. All studies reported using a 
protocol or structure, though the level of detail varied considerably. Some studies outlined 
session structures while others used standardized reminiscence interventions, the most 
popular of which were Haight’s Life Review Model and Life Review Experiencing Form [25, 
31, 41, 43] and the RYCT program [18, 35, 38, 44].   
3.5. Meta-analysis 
3.5.1. Self-reported quality of life - overall 
(See Fig. 2). For the overall evaluation of the effects of reminiscence on quality of life 
post-treatment, eight studies (1,060 participants) were included in the meta-analysis. No 
significant differences between reminiscence and control groups were observed at post-
treatment (random effects, SMD 0.11, 95% CI -0.12 to 0.33; Z = 0.95, P = 0.34).  
Five studies, with 874 participants, also measured at follow-up [18, 19, 23, 30, 35]. All 
five implemented group reminiscence interventions. Again, the SMD was not statistically 
significant (random effects, SMD 0.35, 95% CI -0.11 to 0.80; Z = 1.50, P = 0.13). 
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3.5.1.1. Self-reported quality of life - modality 
 One small study of 23 participants measured self-reported quality of life at post-
treatment following an individual life review intervention, involving life story work [31]. 
Results indicated that life story work had a significant positive effect on self-reported quality 
of life (MD 7.0 points, 95% CI -0.14 to 14.13, Z = 1.92, P = 0.05.  
Seven studies implemented group interventions, of which six used the QoL-AD [18, 19, 
23, 29, 30, 35, 38]. The analysis included 1,037 participants in total, and no significant effect 
was identified (SMD 0.06, 95% CI -0.15 to 0.28, Z = 0.59, P = 0.55).  The findings for group 
reminiscence at follow-up time points have been detailed above (Section 3.5.2).  
 
3.5.1.2. Self-reported quality of life - setting  
Three care home studies were included in the meta-analysis (See Fig. 2). A fixed effects 
analysis of data from 193 participants showed a statistically significant SMD of 0.46 (95% CI 
0.18 to 0.75, Z = 3.17, P= 0.002) in favor of reminiscence interventions. At follow-up, one 
care-home study with 88 participants [23] reported significant effect on the SRQOL (MD 9.8 
points, 95% CI 7.05 to 12.55, Z = 6.98, P < 0.00001). 
Five studies were community-based and included a total of 867 participants (See Fig. 2). 
All five used the QoL-AD scale, and the mean difference between reminiscence and control 
groups was not statistically significant (fixed effects, MD = -0.57 points, 95% CI -1.37 to 0.22; 
Z = 1.41, P = 0.16). In contrast, the mean difference across the two care home studies [29, 
31] that used the QoL-AD was significant, and much larger at 3.58 points (n = 105; 95% CI 
0.66 to 6.51, Z = 2.40, P = 0.02). Four studies [18, 19, 30, 35] measured the effects of 
reminiscence on the quality of life of 786 community-dwelling participants at follow up. The 
mean difference (QoL-AD, fixed effects) was 0.17 points (95% CI -0.79 to 1.13), which was 
not statistically significant (Z = 0.35, P = 0.73).  
 
3.5.2. Proxy rated quality of life 
Five studies with 763 participants used the proxy version of the QoL-AD, in which a family 
carer or care staff member rated the person's quality of life [18, 29, 30, 35, 38]. All five 
implemented group reminiscence interventions. A random-effects model revealed a MD of 
0.35 points (95% CI -1.23 to 1.94) which was not statistically significant (Z = 0.44, P = 0.66). 
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Three also measured at follow-up time points [18, 30, 35] and again, no significant 
difference was identified (MD -0.15 points; 95% CI -1.14 to 0.83, Z = 0.30, P= 0.76). 
 
3.5.3. Observed quality of life  
Two studies used the WIB, which is an observational measure of quality of life [23, 39]. It 
is completed during a minimum of six hours observation of the person undertaking their 
usual activities. There was no indication of an effect on WIB scores at post-treatment across 
154 care home residents (MD 0.00 points, 95% CI -0.17 to 0.18, Z = 0.06, P = 0.95) or at 
follow-up (random effects, MD -0.40 points, 95% CI -1.34 to 0.54, Z= 0.83, P = 0.41). 
 
3.5.4. Communication and interaction - overall 
(See Fig. 3).  Six studies using an assortment of communication and interaction measures 
were included in the post-treatment analysis (in this analysis, negative scores indicate 
improved communication). Data from 249 participants were included. A statistically 
significant difference favouring reminiscence was identified at post-treatment (SMD = -0.51, 
95% CI -0.97 to -0.05; Z = 2.18, P = 0.03).  
At follow up, four studies including 204 participants reported communication outcome 
data [23; 32, 33, 39].  Again, a significant effect favouring reminiscence was identified (SMD 
= -0.49, 95% CI -0.77 to -0.21; Z = 3.40, P = 0.0007).  
 
3.5.4.1. Communication and interaction - modality 
Two studies of individual reminiscence reported post-treatment data on communication 
and interaction, including 96 participants [25, 39]. The overall effect size (SMD, random 
effects) was -0.74 (95% CI -2.38 to 0.89) which was not statistically significant (Z=0.89, P = 
0.37). In contrast, the post-treatment analysis of four studies of group reminiscence, 
including 153 participants [23, 32, 33, 38], did indicate a statistically significant benefit of 
reminiscence in relation to communication and interaction (SMD = -0.39, 95% CI -0.71 to -
0.06; Z = 2.34, P = 0.02). 
Longer-term follow-up data were available from one study of individual reminiscence, 
with no evidence of an effect [39]. Data from three studies (N = 138) of group reminiscence 
were available [23, 32, 33]. Similar to post-treatment, a significant benefit was identified 
(SMD -0.63 points, 95% CI -0.97 to -0.29; Z=3.60, p= 0.0003).   
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3.5.4.2. Communication and interaction - setting 
Three studies that measured communication were community-based and involved 
participants. A significant effect on communication and interaction was identified (SMD -
0.57, 95% CI -1.08 to -0.06; Z = 2.21, P = 0.03). Two studies, including 50 participants, also 
reported communication and interaction outcomes at follow up [32, 33]. Both used the 
withdrawal subscale of the MOSES. The mean difference was -3.64 points (95% CI -7.21 to -
0.06), which was statistically significant (Z = 2.00, P = 0.05). 
Three studies took place in care homes, with 184 participants (See Fig. 3). Here, no 
significant effect was identified (random effects, SMD -0.52, 95% CI -1.29 to 0.24; Z = 1.34, P 
= 0.18). Two care home studies [23, 39], both using the SES, also reported data from 154 
participants at follow up and found a statistically significant MD of -0.93 points (random 
effects, 95% CI -1.77 to -0.09; Z = 2.16, P = 0.03). 
 
3.5.5. Depressed mood - overall 
(See Fig. 4). In mood analyses, negative scores were indicative of improvements in mood. 
Ten studies, including 973 participants, included a measure of depressed mood in post-
treatment evaluation. A non-significant SMD favouring reminiscence interventions was 
identified (SMD -0.03, 95% CI -0.15 to 0.10; Z = 0.40, P = 0.69). At follow-up, data from 747 
participants across six studies were included. Again, the SMD was not statistically significant 
(random effects, SMD -0.16, 95% CI -0.43 to 0.11; Z = 1.15, P = 0.25).  
 
3.5.5.1 Depressed mood - modality 
Four studies, involving 131 participants, used an individual reminiscence approach [25, 
31, 34, 41]. The effect on depressed mood was statistically significant in favour of 
reminiscence (SMD -0.41, 95% CI -0.76 to -0.06, Z = 2.32, P = 0.02). On the other hand, a 
significant difference was not identified in the analysis of the six studies (N=842) that used a 
group approach (SMD 0.03, 95% CI -0.10 to 0.17, Z = 0.49, P = 0.63). 
One small study of individual reminiscence measured depression at follow-up using the 
GDS-SF [41], and reported a significant benefit of reminiscence (MD = -3.70, 95% CI -5.74 to 
-1.66, Z = 3.56, P = 0.0004). Five studies of group reminiscence reported measures of 
depressed mood at follow-up, though all were community-based meaning that the results 
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were confounded with the intervention setting. The SMD was -0.04 (95% CI -0.19 to 0.11) 
which was not statistically significant (Z = 0.52, P= 0.60). 
 
3.5.5.2. Depressed mood - setting 
No effect was identified in the five care-home based studies at post-treatment (See Fig. 
4; SMD -0.19, 95% CI -0.48 to 0.10; Z = 1.32, P = 0.19). The five community-based studies 
(See Fig. 4, N=786) all involved group interventions and also showed no effect on depressed 
mood (SMD 0.01, 95% CI -0.13 to 0.16, Z = 0.20, P= 0.84). The results for longer-term follow-
up were discussed in section 3.5.6.1 above, as all group studies were based in the 
community, the single care home study also provided follow-up data.  
 
3.5.6. Cognition - overall 
(See Fig. 5). Where studies used more than one measure of cognition, the analysis was 
conducted with the most common or extensive assessment. For the AMI and AMI (E) this 
was the PSS sub-scale. Data from 14 studies involving 1,219 participants were analyzed. The 
difference in improvement scores between reminiscence and control groups was just 
statistically significant, in favour of reminiscence (SMD = 0.11, 95% CI 0.00 to 0.23; Z = 1.97; 
P = 0.05).  
The MMSE was the most widely used cognitive measure, employed in nine studies (n = 
437). A fixed effects analysis of data taken from this measure yielded a statistically 
significant MD of 1.87 points (95% CI 0.54 to 3.20; Z = 2.76, P = 0.006). On the other hand, a 
significant effect of reminiscence was not identified on either sub-scale of the AMI and 
extended AMI (E), which were used by four studies (n = 456).  
Nine studies reported follow-up data from a total of 983 participants. Neither the overall 
effect size (SMD = 0.04, 95% CI -0.09 to 0.17; Z = 0.61, P = 0.54) nor the differences on 
individual measures were significant when assessed individually. The MD on the MMSE at 
follow-up was 1.8 points (95% CI -0.06 to 3.65) which was not statistically significant, though 
it was close (Z = 1.90, P = 0.06). 
 
3.5.6.1. Cognition - modality  
 16 
Individual reminiscence interventions were implemented by five studies [25, 31, 34, 39, 
41]. Data from 196 participants revealed a significant effect size in favour of reminiscence 
(SMD = 0.32, 95% CI 0.04 to 0.61; Z = 2.22, P= 0.03).  
In contrast, a significant effect was not identified across the nine studies of group 
reminiscence, involving 1023 participants (SMD 0.07, 95% CI -0.05 to 0.20; Z = 1.17, P = 
0.24). However, MMSE data for 281 participants was reported by six studies of group 
reminiscence at post-treatment. When data from this measure was considered 
independently, a statistically significant effect in favor of group reminiscence was identified 
(MD 1.81 points, 95% CI 0.17 to 3.46; Z = 2.16, P = 0.03). 
At follow-up, a significant effect was not found in analyses of either modality.  
 
3.5.6.2. Cognition - setting  
Six studies, involving 230 participants, were based in care homes (See Fig. 5). A significant 
effect in favour of reminiscence was identified (SMD 0.29, 95% CI 0.03 to 0.56; Z = 2.19, P = 
0.03). Eight studies (n = 989) were carried out in community settings. The benefit to 
cognitive function in this context was not statistically significant (SMD 0.07, 95% CI -0.05 to 
0.20, Z = 1.13, P = 0.26). At follow-up, no significant effects were identified in care home (2 
studies, 83 participants) or community settings (7 studies, 900 participants).  
 
3.5.7. Adverse outcomes.  
While no adverse events were observed on the outcome measures of interest, two 
studies reported incidences of adverse outcomes. Charlesworth and colleagues [18] 
reported three 'serious adverse events' that were attributable to the RYCT intervention. 
Specific details were not given, though it was reported that these events did not lead to 
withdrawal from the trial. Woods and colleagues [35] reported one adverse event, in which 
a participant became upset in one of the intervention sessions relating to marriage. There 
was a detailed protocol in place for dealing with distressing events, which was 
implemented. While adverse events are regrettable, it is important to view them in context 





This is the largest review of RT for people with dementia to date, including 22 RCTs and 
more than 1,900 participants. The results of the meta-analyses, which included 16 studies 
and data from 1,749 participants, provide the strongest evidence thus far that RT can 
potentially benefit people with dementia in the domains of quality of life, communication, 
mood, and cognition. However, these effects are relatively small and inconsistent across 
reminiscence modalities (group/individual) and settings (care home/community).  
Included studies cover various reminiscence activities including simple reminiscence, life 
review, joint reminiscence work, and music listening reminiscence. However, the variation 
between interventions was so great that even interventions that are labelled the same (e.g. 
simple reminiscence) were often implemented in significantly different ways. Therefore, it 
was not possible to run sub-group analyses of intervention type. Reporting of reminiscence 
protocols is becoming more commonplace, but detailed manuals and standardised practices 
need to be developed in order to reliably compare specific intervention types. Similarly, it 
was not possible to compare the effects of reminiscence across ‘stages’ of dementia as 
studies typically recruited participants with mild to moderate dementia but did not report 
separate data for each group.  Intervention intensities and durations also varied widely 
across included studies. In addition to treatment-as-usual groups, some studies also 
compared reminiscence to alternative activities or measured additional outcomes but these 
were beyond the scope of the current review. Despite growing interest in digital 
reminiscence, no studies of this type of RT met the inclusion criteria.  
 
The quality and volume of studies have improved since earlier reviews of RT for 
dementia. Four large multi-center trials are included, in addition to some smaller studies of 
reasonable quality. The volume of data made it possible to exclude studies at an unclear risk 
of randomization bias from the meta-analysis, without undermining it. Furthermore, there 
were sufficient data to carry out subgroup analyses of intervention modalities and settings 
for the first time. Although most included studies reported using an intervention protocol or 
structure, several did not report these in sufficient detail. In several cases, additional study 
information had to be requested as published reports did not include enough detail, 
particularly in relation to randomization and allocation concealment. Almost 40% of 
included studies did not report adequate detail regarding allocation concealment. Studies 
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were not excluded from the meta-analysis on this basis as good practice was assumed, 
which is a limitation of this review.  
RT was associated with significantly improved self-reported quality of life, compared to 
control groups at both post-treatment and follow-up, but only in care home settings. One 
study of individual reminiscence reported a significant benefit of RT on self-reported quality 
of life at post-treatment [31]. However, no significant effect was identified in studies of 
group reminiscence, or community-based studies. No significant benefit was identified on 
observed, or proxy-rated quality of life.   
There was a significant improvement in communication scores of reminiscence groups 
compared to control groups at both post-treatment and follow-up. However, in sub-group 
analyses of intervention modality, a benefit was only identified in group approaches. In the 
subgroup analysis of setting, there was a significant benefit to communication in community 
settings at post-treatment, and in both community and care home settings at follow-up.  
There was no benefit of reminiscence to depressed mood overall. However, in subgroup 
analyses, individual reminiscence was associated with improvements in depressed mood at 
both post-treatment and follow-up. Though it should be noted that just one small study 
measured depressed mood at follow-up [41]. No significant effects were observed in 
subgroup analyses of group reminiscence, community-based reminiscence, or care home 
based reminiscence. There was no significant benefit of reminiscence to anxiety. 
In relation to cognitive outcomes, those who received RT exhibited greater 
improvements than controls at post-treatment. However, in subgroup analyses, a significant 
effect was identified only when the intervention was individual or based in a care home. At 
follow-up, no significant effects were identified across any of the subgroup analyses. When 
MMSE scores are considered independently, results of this review (nine studies, N = 437, 
MD = 1.87; 95% CI 0.54 to 3.20) bear similarity to the Cochrane Review of Cognitive 
Stimulation for dementia ([46]; N = 600, MD = 1.74 points; 95% CI 1.13 to 2.36). However, 
when the overall effect is considered, results of cognitive stimulation (14 studies, N= 658, 
SMD =0.41, 95% CI 0.25 to 0.57) appear more positive than those of the current review (14 
studies, N = 1229, SMD = 0.11, 95% CI 0.00 to 0.23).   
 Results of the current review are in line with previous reviews of RT for dementia. 
Improvements in cognition and mood reflected have often been cited [1, 12-16]. Similarly, 
individual reminiscence and RT interventions based in care homes have previously been 
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associated with improved quality of life [16]. Communication has been measured less often 
in previous reviews, but a significant benefit of group reminiscence to communication seen 
in the current review has been identified previously [17]. The results of the current study 
suggest that it is now an important outcome of RT to consider, particularly in group-based 
RT. 
 
5. Expert Commentary  
RT can now be viewed as an eco-psychosocial intervention, with a credible evidence base. 
There is positive and promising evidence that it can improve quality of life, communication, 
depressed mood, and cognition among people with dementia, though effects are small and 
vary considerably across intervention modalities, settings, and outcomes. It remains unclear 
which modality of reminiscence is superior as individual reminiscence may benefit cognition 
and mood, while group reminiscence may have positive outcomes in relation to 
communication.  
Care home settings appear to show the widest range of benefits, and effects on quality of 
life appear greatest here. Overall, it is unclear which modality of reminiscence is most 
effective in community settings, but in care home settings individual reminiscence seems 
most powerful. Perhaps people in care homes are more receptive to positive effects of 
reminiscence because the person has moved from their home, relinquished their belongings 
(and memory triggers), and transitioned to communal living, making identity maintenance a 
particular issue. This may be particularly true when the reminiscence intervention is 
accompanied by a life storybook. A possible alternative explanation is that care home 
residents typically find themselves in less stimulating and active environments than their 
community-dwelling counterparts (or at least those who take part in research studies). 
Perhaps in care home environments, looking back is more relied upon for stimulation, while 
those in the community may be surrounded by more current and future activities.  
 Group-based reminiscence approaches were associated with positive outcomes for 
communication, possibly due to the nature of social groups. People can use reminiscence to 
find common ground, and may become more comfortable and confident communicating 
with one another over the course of the intervention. On the other hand, individual 
reminiscence appeared to have a positive effect on mood and cognition, which was not 
identified in data from group interventions. Almost 30 years ago, Haight and Dias [47] 
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examined the key variables in reminiscing and concluded that structured, evaluative Life 
Review was the most therapeutic reminiscence method.  In the current review, individual 
reminiscence interventions were generally based around Life Review, while group 
interventions were typically the less structured ‘simple reminiscence’ which may be a 
possible explanation for these results. However, the wide range of reminiscence 
interventions across included studies makes it difficult to compare and contrast results.  
Studies that implemented individual reminiscence interventions were typically small and 
took place in care homes, while group interventions were generally much larger and mostly 
took place in community settings. Therefore, it is difficult to be certain of what underpins 
any differences in outcomes between individual and group interventions. 
The meta-analyses were heavily influenced by three large community-based studies 
that implemented group approaches, all of which found no positive effects of reminiscence 
[18, 19, 35]. Furthermore, these RCTs had high rates of attrition, and data were extracted 
from ITT analyses (as per the review protocol) making it likely that the intervention effects 
were underestimated. Similarly, it was not possible to distinguish between simple and 
integrative RT approaches, or between varying lengths of exposure to RT in the analyses. 
While the results of this review indicate the potential for reminiscence to improve 
psychosocial outcomes for people with dementia, it is difficult to translate what these 
significant differences actually mean in terms of real-life benefit to people with dementia. 
For the majority of measures, there are currently no international agreed-upon benchmarks 
to apply in this situation. The benefits observed on the MMSE may however be viewed as 
approximating to preventing 6 months of cognitive decline [48].  
  Although no studies of digital reminiscence met the inclusion criteria for the current 
review, this is an exciting avenue of RT which is growing in popularity. Using multimedia 
materials may have the ability to make reminiscence and life story work more powerful 
experiences with potentially greater effects. A recently published protocol outlines a 
planned RCT of a structured individual life story work intervention, involving digital life 
storybooks for community-dwelling people with dementia and their caregivers, which 
should provide a very helpful contribution to the literature [49]. 
In future research, a large-scale RCT of individual integrative reminiscence work would 
be helpful to ascertain if the promising results in the current review can be replicated on a 
larger scale.  Efforts should be made to learn more about the characteristics of participants 
 21 
that are associated with better outcomes and levels of engagement, so that interventions 
can be tailored and targeted effectively and efficiently. The development, reporting, and use 
of more detailed standardized manuals and protocols is crucial in progressing the field, so 
that common approaches can be shared and developed. 
 
6. Five-year view 
In five years time, we anticipate that reminiscence will be largely augmented by digital 
multimedia materials. Growing availability and accessibility of ICT, particularly touchscreen 
devices, will make it possible for individuals and care homes to ‘carry' life story books or 
personalized reminiscence stimuli with them should they move to a care home or need to 
spend time in acute care settings. Care staff will be able to use this readily accessible wealth 
of information to devise and implement plans for person-centred care without delay. 
Currently, the literature on digital reminiscence is developing, but we anticipate it will 
progressed well over the next five years, beginning with Elfrink and colleagues’ RCT 
mentioned above [49].  
 
Key issues 
• Reminiscence Therapy is a popular psychosocial intervention for people with 
dementia, in which a range of prompts are used to stimulate past memories.  
• 22 studies (n=1972) are included in the current review, with 16 (n=1,749) included in 
the meta-analysis 
• Included studies cover various reminiscence activities including simple reminiscence, 
life review, joint reminiscence work, and music listening reminiscence. Intervention 
intensities and durations varied widely across included studies 
• RT had small but significant, positive effects on quality of life, mood, cognition, and 
communication, but effects were inconsistent across intervention modality 
(group/individual) and setting (care home/community).  
• It remains unclear which modality of reminiscence is superior as individual 
reminiscence may benefit cognition and mood, while group reminiscence may have 
positive outcomes in relation to communication. Effects on quality of life appear 
greatest in care home settings. 
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• Diversity in reminiscence approaches makes it difficult compare them, and the 
development, evaluation, use, and sharing of standardized approaches would help 
to progress research and practice in this area. 
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Table 1. Description of included studies and bias ratings 
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Gonzalez et al. 
2015 




60 mins/week for 
10weeks. 
? ? ? + + ? ? + 
Haight et al. 
2006 
30 care home residents 
with a dementia 
diagnosis 
Individual life 
review with the 




+ ? ? + + n/a + + 
Hsieh et al. 
2010 
61 care home residents 




for 12 weeks 
? ? ? ? + n/a ? + 
Ito et al. 2007 
40 care home residents 
with VD* 
Group RT 
60mins/week for 12 
weeks. 
+ + + + + n/a ? + 
Lai et al. 2004 
66 care home residents 
with a dementia 
diagnosis* 
Individual life 
review with the 
production of a life 
story book 
30 mins/week for 
6weeks 
+ ? + + + n/a + + 
Melendez et al. 
2015 
30 community residents 
with AD 
Group RT 
30 mins, twice/week 
for 10weeks 
+ + + + + ? + + 
Morgan & 
Woods 2012 
17 care home residents 




life review Model). 
30-60mins/week for 
12weeks 
+ ? ? + + n/a + + 
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O’ Shea et al. 
2014 
304 care home 





14weeks (range 12 – 
17 weeks) 
+ + + + + + + + 
Subramaniam 
et al. 2013 
24 care home residents 




production of Life 
Storybook 
1hour/week for 
average of 12weeks. 
+ + + + + n/a + + 
Särkamo et al. 
2013 
59 community residents 
with a dementia 

























+ + ? + + n/a + + 
Thorgrimsen et 
al. 2002 
11 community residents 
with a dementia 
diagnosis (and a 
caregiver) 




+ + + + + n/a + + 
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Van Bogaert et 
al. 2016 
72 care home residents 






+ + + + + n/a + + 




residents with a 
dementia diagnosis 
(and their caregivers) 
Joint Group RT 
(RYCT) 
 
2hrs/week for 12 
weeks + maintenance 
2hrs/month for 
7months 
+ + + + + n/a + + 
Yamagami et al. 
2012 
54 care home residents 





? ? ? + + n/a + + 
 
* The number of participants in groups relevant to the current review, rather than the total number of participants in the study.  
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Fig. 4. Meta-analysis cognition 
  
